Lecturer in Law
Kamil Ali-Jackson, Esquire is the co-founder, Chief Legal Officer, Chief Compliance Officer and Secretary of the Board of Aclaris Therapeutics, Inc., a NASDAQ-listed biopharmaceutical company. Kamil’s career spans more than 35 years of experience as a serial entrepreneur and attorney in emerging, mid-size and large life sciences companies. Kamil is a C-suite leader and business partner with extensive legal, corporate secretarial/board governance, compliance, mergers and acquisitions, business development, product licensing, and human resources experience.
Kamil has co-founded several specialty pharmaceutical companies and successfully transitioned those companies through multi-million dollar acquisitions by global pharmaceutical companies.
Kamil currently serves on the board of directors, audit committee, compensation committee and is the chair of the nominating and corporate governance committee of PDS Biotechnology Corporation, a NASDAQ-listed clinical stage immunotherapy company.
Kamil has also served on several nonprofit boards, is an inaugural member of the Princeton University Dean for Research External Advisory Council for Innovation and Entrepreneurship, a member of the Forum of Executive Women, and adjunct lecturer at the University of Pennsylvania Carey Law School. Kamil is also an active member of her community serving for more than 20 years as the Vice Chair of the East Bradford Township (Pa.) Zoning HearingBoard.
Kamil received a Juris Doctorate from Harvard Law School and a Bachelor of Arts in politics from Princeton University. Kamil is married to an attorney and is the mother of four children.